The DOI matches its Crossref record; 14 of the 15 references it cites were found in a registry or an index; 7 of the 16 sources its claims cite were checked for support.
Assessment of current prescribing practices using World Health Organization core drug use and complementary indicators in selected rural community pharmacies in Southern India.
Open accessAbstract
One thousand fifty-two patients were prospectively interviewed and their prescriptions analyzed in five busy community pharmacies in Tamil Nadu, South India to assess WHO core drug use and complementary indicators.
Overview
CoChat Summary
## TL;DR
This prospective cross-sectional study of 1,052 patient encounters across five community pharmacies in rural southern India found heavy brand-name prescribing and relatively high polypharmacy, with an average of 3.7 drugs per encounter. Most WHO indicators were acceptable, but generic prescribing was very low (2.5% of drugs), while formulary use was very high (99.8%).
## Key findings
- Across 1,052 encounters, 3,936 drugs were prescribed; only 2.5% (100) were prescribed by generic name, and about 92% of encounters contained no drugs prescribed by generic name.
- Mean number of drugs per encounter was 3.7; more than 53.2% of encounters contained four drugs.
- 22% of encounters had an antibiotic in the abstract, while the Results section reports 58.8% of prescriptions contained at least one antibiotic; 7.2% of encounters had an injection in the abstract, while the Results section reports 24.3% contained at least one injection.
- 99.8% of drugs were prescribed from formulary/available stock, and 99.8% of drugs prescribed were dispensed; all patients were treated with drugs and no patient was treated without a drug.
## Methods
- Prospective, cross-sectional survey in five randomly selected busy community pharmacies in a northern district of Tamil Nadu, South India, conducted from June 2014 to May 2015.
- 1,052 patient encounters/prescriptions were included; two trained clinical pharmacists observed prescriptions and interviewed patients using an investigator-developed data collection form.
- Indicators were analyzed using WHO prescribing, health facility, patient care, and complementary indicators; data were entered and analyzed in Microsoft Excel 2007.
## Limitations
- The paper states that only 1,052 prescription encounters were sampled and that a higher number would be needed for better results; it also says the findings cannot be generalized to overall prescribing practice of all private practitioners.
- The paper states that prescribing-indicator studies are not exhaustive and do not explain why drugs are prescribed.
- The paper states WHO prescribing indicators are mainly designed for outpatient treatment in health centers, dispensaries, or hospital outpatient departments and are less useful in specialty outpatient clinics; this is a methodological limitation of the tool, as stated in the paper.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
5 Valid · 1 Not valid · 3 Not checked · 22 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Though there is a guideline stating that the durgs should be prescribed using the generic names, adherence to that can hardly be observed across this subcontinent [6, 7].”
§ Assessment of current prescribing practices using World Health Organization core drug use and complementary indicators in selected rural community pharmacies in Southern India > Background World Health Organization (WHO) defined rational use of drugs as “patients receive medicines appropriate to their clinical needs, in doses that meet their own individual requirements for an adequate period of time, at the lowest cost to them and their community [1].” Due to the lack of clear, comprehensive, and rational drug policy, the production of pharmaceutical preparations in India is distorted for the most part. Indian markets are flooded with more than 70,000 formulations. Thousands of drug companies operate in India and they manufacture generic preparations with different brand names. Huge number of vitamins, tonics, and multi-drug combinations that are unique to Indian market are also manufactured and marketed here. This entails the drug manufacturers to enter into fierce competition, which makes them to encourage the prescribers to prescribe branded medicines, often in exchange of small favor. This benefits the manufacturing companies, but it also results in drugs being prescribed without any necessity and combinations that are not rational [2, 3]. A concerted effort is needed to readjust pharmaceutical actions and practices aiming at the rational use of medications. WHO developed Medication Use Indicators, including Prescription Indicators with an aim to evaluate the services provided to the population in regards to medications [4]. Prescription Indicators allow the therapeutic actions taken in similar institutions to be ascertained, enabling subsequent comparison of parameters between them, and to evaluate the population’s medication needs and determine the most frequently used medications in a given place [4]. In addition, these indicators enable the investigator to identify the prescription profile and quality of services offered to the population. The prescription Indicators are as follows [4]: > The current status of drug use pattern in South India
What the sources say
- Supportedcites [6] Bhargava A, et al. The crisis in access to essential medicines in India: key issues which call for action. Indian J Med Ethics. 2013;10(2):86–95. source
Passage [1] (Introduction, 'Prescription malpractice') states the qualifying guideline and the adherence point together: the Medical Council of India's code of ethics explicitly requires that 'Every physician should, as far as possible, prescribe drugs with generic names', yet 'this practice is seldom followed'. Passage [2] reinforces it ('the government's advice to all doctors to prescribe by generic name cannot be translated into practice'; generic-name prescriptions in the private sector 'haven't succeeded'), and passage [3] notes most Indian prescribers do not recognise the equivalence of unbranded and branded medicines. The only looseness is the citing sentence's 'across this subcontinent' where our copy speaks of India; the substance attributed to this source is stated. (LLM, conf=0.90)
- Partly supportedcites [7] Patel V, et al. Irrational drug use in India: a prescription survey from Goa. J Postgrad Med. 2005;51(1):9–12.Experimental — accuracy not yet measured
The Goa survey supports the substance of non-adherence to generic-name prescribing in India: the Results report that 96.6% of 990 prescriptions 'consisted entirely of branded medicines' (over 90% for both public and private practitioners), and the Discussion states that 'branded medicines were more commonly prescribed than generic preparations. This finding runs counter to the recommendations of medical ethics bodies and the WHO.' However, our copy frames the counter-position as WHO/ethics-body recommendations and the absence of 'a clear, comprehensive and rational drug policy' in India, not as a specific national guideline mandating generic-name prescribing. The claim's extension 'across this subcontinent' also outruns the source: the Discussion notes similar findings from other Indian studies but explicitly limits generalisability — 'the study was located in only one pharmacy and may thus not be representative of prescription patterns across the state' — and no passage addresses the Indian subcontinent beyond India. (LLM, conf=0.75)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Use of antibiotics was 22 %”
§ Assessment of current prescribing practices using World Health Organization core drug use and complementary indicators in selected rural community pharmacies in Southern India > Abstract > Results
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“percentage of encounters with an injection was 7.2 %”
§ Assessment of current prescribing practices using World Health Organization core drug use and complementary indicators in selected rural community pharmacies in Southern India > Abstract > Results
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“out of total drugs prescribed (3936), only 2.5 % (100) drugs were prescribed by generic name.”
§ Assessment of current prescribing practices using World Health Organization core drug use and complementary indicators in selected rural community pharmacies in Southern India > Abstract > Results
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Mean number of drugs per encounter was 3.7.”
- Also stated in: § Results · plain
“with an average number of drugs per encounter of 3.7”
§ Assessment of current prescribing practices using World Health Organization core drug use and complementary indicators in selected rural community pharmacies in Southern India > Abstract > Results
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Results · plain
14 more claims
Create a free account to see all 31 claims and to verify the 3 references still open.
- It may state two separate claims as one. 6
- Probably not a substantial claim. 9
Citations
Cites
How to investigate drug use in health facilities. Selected drug use indicators
Ghei, P. (1995) · Health Policy · doi:10.1016/0168-8510(95)90068-3 · Cited by 366
Field tests for rational drug use in twelve developing countries
Hogerzeil, H. V., Bimo, Ross-Degnan, D., Laing, R. O., Ofori-Adjei, D., Santoso, B., Azad Chowdhury, A. K., Das, A. M., Kafle, K. K., Mabadeje, A. F. B., et al. (1993) · The Lancet · doi:10.1016/0140-6736(93)92760-q · Cited by 328
How to investigate drug use in health facilities : selected drug use indicators
Action Programme on Essential Drugs (1993) · Medical Entomology and Zoology · Cited by 287
Linden, M., Lecrubier, Y., Bellantuono, C., Benkert, O., Kisely, S., & Simon, G. (1999) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199904000-00007 · Cited by 133 · cited 1×
“Studies have indicated that majority of prescriptions in India are of drugs of “doubtful efficacy” [5–7].”
BackgroundIrrational drug use in India: a prescription survey from Goa.
(2005) · PubMed · Cited by 128
Prescribing patterns among medical practitioners in Pune, India.
Kshirsagar, M. J., Langade, D., Patil, S. S., & Patki, P. S. (1998) · Europe PMC (PubMed Central) · Cited by 68
Assessment of prescribing practices among urban and rural general practitioners in Tamil Nadu
Ganeshkumar, P., Gopalakrishnan, S., & Katta, A. (2013) · Indian Journal of Pharmacology · doi:10.4103/0253-7613.111931 · Cited by 53
Amaha, N. D., Berhe, Y. H., & Kaushik, A. (2018) · BMC Research Notes · doi:10.1186/s13104-018-4000-7 · Cited by 35
Indicadores do uso de medicamentos na atenção primária de saúde: uma revisão sistemática
André Silva, Maciel, G., Wanderley, L., & Wanderley, A. G. (2017) · Revista Panamericana de Salud Pública · doi:10.26633/rpsp.2017.132 · Cited by 34
A study of drug prescribing pattern using WHO prescribing indicators in the state of Goa, India
Chandelkar, U., & Rataboli, P. (2014) · International Journal of Basic & Clinical Pharmacology · doi:10.5455/2319-2003.ijbcp20141221 · Cited by 29
Research works printed but not linked: 1
- WHO. The rational use of drugs. Report of a conference of experts, Nairobi, 25–29 November 1985. Geneva: World Health Organization; 1987.
Cited by
Lugada, E., Komakech, H., Ochola, I., Mwebaze, S., Oteba, M. O., & Ladwar, D. O. (2022) · Journal of Pharmaceutical Policy and Practice · doi:10.1186/s40545-022-00412-4 · Cited by 100
Amaha, N. D., Weldemariam, D. G., Abdu, N., & Tesfamariam, E. H. (2019) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-019-0620-5 · Cited by 75
Jafarzadeh, A., Ahari, A. M., Najafi, M., Yousefi, M., & Dalal, K. (2021) · BMC Public Health · doi:10.1186/s12889-021-11100-4 · Cited by 101
Demoz, G. T., Kasahun, G. G., Hagazy, K., Woldu, G., Wahdey, S., Tadesse, D. B., & Niriayo, Y. L. (2020) · Infection and Drug Resistance · doi:10.2147/idr.s262104 · Cited by 68
Moye-Holz, D., & Vogler, S. (2021) · Applied Health Economics and Health Policy · doi:10.1007/s40258-021-00670-4 · Cited by 60
Metadata
- Authors
- Aravamuthan, A., Arputhavanan, M., Subramaniam, K., & Udaya Chander J, S. J.
- ORCID
- Subramaniam, Kannan
- Venue
- Journal of Pharmaceutical Policy and Practice
- Publisher
- Informa UK Limited
- Published
- 2016-07-19
- Volume
- 10
- Issue
- 1
- Pages
- 1-1
- ISSN
- 2052-3211 (ISSN-L)
- PMC
- PMC4955117
- OpenAlex
- W2497264936
- Semantic Scholar
- e59b81a0a7fb76ea2b864d4193694deda231e83e
- Cited by
- 81
- References
- 15
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 8 · 2023: 6 · 2022: 14 · 2021: 18 · 2020: 10 · 2019: 10 · 2018: 6 · 2017: 3
- FWCI
- 12.30
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Journal of Pharmaceutical Policy and Practice (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Topics
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Pharmaceutical Economics and Policy
- Health Sciences › Health Professions › Pharmacy › Pharmacy and Medical Practices
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Keywords
- prescribing patterns, WHO core drug use indicators, rational drug use, number of drugs per prescription, antibiotic prescribing, pharmaceutical policy, drug availability, Tamil Nadu
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Assessment of current prescribing practices using World Health Organization core drug use and complementary indicators in selected rural community pharmacies in Southern India. https://app.cochat.ai/papers/10.1186/s40545-016-0074-6
- The paper
- Aravamuthan, A., Arputhavanan, M., Subramaniam, K., & Udaya Chander J, S. J. (2017). Assessment of current prescribing practices using World Health Organization core drug use and complementary indicators in selected rural community pharmacies in Southern India. Journal of Pharmaceutical Policy and Practice. https://doi.org/10.1186/s40545-016-0074-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.